UMediC to benefit from government’s focus on healthcare

HLIB Research is upbeat about the medical device maker’s business going forward.

PETALING JAYA: Despite UMediC Group Bhd (UMC) incurring a surge in operating costs, Hong Leong Investment Bank Research (HLIB Research) is upbeat about the medical device maker’s business going forward.

The research house said its optimism remains intact, fuelled by the company’s robust capacity expansion and strategic advantage in capitalising on the government’s commitment to increase public healthcare expenditure to 5% of gross domestic product (GDP).